Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Inhibitors of histone deacetylases (HDACs) induce growth arrest, differentiation, and apoptosis of colon cancer cell lines in vitro and have demonstrated anti-cancer efficacy in clinical trials. Whereas a role for HDAC1 and -2 in mediating components of the HDAC inhibitor response has been reported, the role of HDAC3 is unknown. Here we demonstrate increased protein expression of HDAC3 in human colon tumors and in duodenal adenomas from Apc1638(N/+) mice. HDAC3 was also maximally expressed in proliferating crypt cells in normal intestine. Silencing of HDAC3 expression in colon cancer cell lines resulted in growth inhibition, a decrease in cell survival, and increased apoptosis. Similar effects were observed for HDAC2 and, to a lesser extent, for HDAC1. HDAC3 silencing also selectively induced expression of alkaline phosphatase, a marker of colon cell maturation. Concurrent with its effect on cell growth, overexpression of HDAC3 and other Class I HDACs inhibited basal and butyrate-induced p21 transcription in a Sp1/Sp3-dependent manner, whereas silencing of HDAC3 stimulated p21 promoter activity and expression. However, the magnitude of the effects elicited by silencing of individual Class I HDACs was significantly less than that induced by HDAC inhibitors. These findings identify HDAC3 as a gene deregulated in human colon cancer and as a novel regulator of colon cell maturation and p21 expression. These findings also demonstrate that multiple Class I HDACs are involved in repressing p21 and suggest that the growth-inhibitory and apoptotic effects induced by HDAC inhibitors are probably mediated through the inhibition of multiple HDACs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, HDAC3 has been suggested to be involved in carcinogenesis by affecting cell differentiation and apoptosis (52).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [52]
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Histones and histone modifications
Peterson, C. L., & Laniel, M.-A. (2004) · Current Biology · doi:10.1016/j.cub.2004.07.007 · Cited by 1,313
Intestinal Epithelial Cell Surface Membrane Glycoprotein Synthesis
Weiser, M. M. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44141-0 · Cited by 1,098
Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression
Laherty, C. D., Yang, W.-M., Sun, J.-M., Davie, J. R., Seto, E., & Eisenman, R. N. (1997) · Cell · doi:10.1016/s0092-8674(00)80215-9 · Cited by 938
Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2
Velcich, A., Yang, W., Heyer, J., Fragale, A., Nicholas, C., Viani, S., Kucherlapati, R., Lipkin, M., Yang, K., & Augenlicht, L. (2002) · Science · doi:10.1126/science.1069094 · Cited by 936
Self-citationLost in Transcription: p21 Repression, Mechanisms, and Consequences
Gartel, A. L., & Radhakrishnan, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3995 · Cited by 818
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2672 · Cited by 760
Research works printed but not linked: 9
- Mariadason, 1997, Am. J. Physiol., 272, G705
- Heerdt, 1994, Cancer Res., 54, 3288
- Mei, 2004, Int. J. Oncol., 25, 1509
- Fischle, 2001, Biochem. Cell Biol., 79, 337, 10.1139/o01-116 · DOI · Paper page
- Mariadason, 2001, Cancer Res., 61, 3465
- Sowa, 1999, Cancer Res., 59, 4266
- Mariadason, 2003, Cancer Res., 63, 8791
- Yang, 2001, Cancer Res., 61, 565
- Bailey, 1999, Mol. Endocrinol., 13, 1155, 10.1210/mend.13.7.0305 · doi:10.1210/mend.13.7.0305 · Paper page
Cited by
Items 501–600 of 611
The Role of Histone Deacetylases in Cytokine Regulation in Human Gestational Tissues
Munro, S. K. (2013) · ResearchSpace (University of Auckland) · Cited by 2
Huang, H.-L., Lee, H., Tsai, A.-C., Peng, C.-Y., Lai, M.-J., Wang, J.-C., Pan, S., Teng, C., & Liou, J. (2012) · PLoS ONE · doi:10.1371/annotation/ab4fff87-6a32-4718-aa4c-91658f164b8d · Cited by 1
Whole Grains and Their Constituents in the Prevention of Colon Cancer
Pajari, A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9800-9_10 · Cited by 1
“In normal colonocytes butyrate has been shown to increase cell proliferation (Sakata 1987; Lupton and Kurtz 1993), whereas in colon cancer cell lines butyrate has promoted expression of differentiation markers ( Whitehead et al. 1986 ) and induced apoptosis (Hague et al. 1995).”
BackgroundExpression of HDAC1 in leukemia cells
Sethi, H. (2012)
Roles of Cytoplasmic Deacetylase Hdac6 in Oncogenic Tumorigenesis
Lee, Y. (2008) · DukeSpace (Duke University)
Molecular roles of short chain fatty acids in colorectal cancer
Lu, C. (2011) · ResearchOnline at James Cook University (James Cook University) · doi:10.25903/40r8-zj02
An Overview of Epigenetic Mechanisms in Health and Disease
Westerland, C., & Karagiannis, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0706-9_3
Drugs Affecting Epigenetic Modifications of ABC Transporters for Drug Resistance
Satake, K., Toyoda, Y., & Nakagawa, H. (2014) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-09801-2_11
Moreno, D. A. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2008.tde-07052009-120246
Histone Deacetylase 8i n NeuroblastomaTumorigenesis
Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp‐Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2009)
Carlberg, C., Polly, P., Campbell, M. J., & Park, R. (2014)
Effect of DNA methylation and histone modification during the de-velopment of cloned animals
Guo, L., Li, H., & Han, Z. (2010) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2010.00762
“收稿日期: 200911; 修回日期: 20100319 基金项目:国家自然科学基金项目(编号:30770245)和国家高技术研究发展计划项目(863计划)(编号:2008AA101006)资助 作者简介:郭磊(1984), 男, 博士研究生, 专业方向:发育生物学。Tel: 010-64807055; E-mail: guolei@ioz.ac.cn 通讯作者:韩之明(1974), 女, 副研究员, 博士, 专业方向:发育生物学。Tel: 010-64807090; E-mail: hanzm@ioz.ac.cn Keywords: somatic cell nuclear transfer; epigenetic modifi…”
BackgroundInfluentialCharacterization of the interaction between MIER1β and lysine 27 of Histone 3
Ferguson, J. L. (2015) · Memorial University Research Repository (Memorial University)
Epigenomics of Intestinal Disease
Kelly, D. R., & Alenghat, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803239-8.00015-6 · Cited by 1
Novel mechanisms of transcriptional regulation by leukemia fusion proteins
Gow, C. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Chapter 11 Zyfl amend and Prostate Cancer Therapy
Whelan, J. N., Zhao, Y., Huang, E., MacDonald, A., & Donohoe, D. R. (2016) · Traditional herbal medicines for modern times · doi:10.1201/9781315370156-12 · Cited by 1
Studies Towards Broadening The Substrate Profile And Regulation Of Histone Deacetylase 1
Nalawansha, D. A. (2016) · Human Biology
The role of physical activity in the molecular regulation of colon cancer risk
Shaw, B. (2015) · UEA Digital Repository (University of East Anglia)
Mangian, H. J. (2014) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Wright, L. C. (2017) · Figshare
Identification and characterisation of novel cancer testis antigens in human cancer cells
Alsiwiehri, N. O. (2017) · Bangor University Research Portal (Bangor University)
Luk, I. Y. (2017) · Minerva Access (University of Melbourne)
Akentieva, N., Gizatullin, A. R., Гончарова, С. А., Raevskaya, T. A., Goryachev, N. S., Shkondina, N. I., Prichodchenko, T. R., Vystorop, I. V., & Сакенович, Ш. С. (2019) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747818040037
Selenium modulation of gut epithelial cell stress responses
Moore, A. N. (2017)
Natural molecules as modulators of epigenetic silencing in human cells for cancer care and aging
Kosianova, A. A., Tiasto, V., Yatsunskaya, M., Khotimchenko, Y. S., & Kagansky, A. (2020) · Biological Communications · doi:10.21638/spbu03.2020.405
Urdiciain, A., Bermudez‐Lekerika, P., Meléndez, B., REY, J. A., Idoate, M. A., Galdo, N. A. R., & Castresana, J. S. (2021) · Glioma · doi:10.4103/glioma.glioma_5_21
Dutta, A., Datta, S., & Snehlata, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85652-2.00011-7
Recent Interpretations of the CPLR by New York Appellate Courts
Goldberg, B. D., & Montes, R. J. (2011) · Albany law review
Mucinous Colorectal Cancer Oxidative Stress and Therapeutic MicroRNAs
Ganesan, H., Kumar, M. M., Banerjee, A., Zhang, H., Sun, X., & Pathak, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_85-1
Epigenomics of intestinal disease
Hashimoto‐Hill, S., Kelly, D. R., & Alenghat, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823928-5.00018-9
Jain, R., Gupta, M., & Epstein, J. A. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1883-2_15
The E2F1-responsive microRNA-449 promotes apoptosis
Lizé, M. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-480
Ghisi, M., & Johnstone, R. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1393-0_21
Herp, D., Ridinger, J., Robaa, D., Shinsky, S. A., Schmidtkunz, K., Yesiloglu, T. Z., Bayer, T., Sehr, P. A., Gunkel, N., Miller, A. K., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12440096 · Cited by 2
“Benzhydroxamates were reported as selective HDAC8 inhibitors.72 Since for Tubastatin A, a “selective” HDAC6 inhibitor, effects against HDAC10 were shown, a set of oxazole compounds was included which had been reported by us as selective HDAC6 inhibitors (see Table 4).73 17 Panobinostat (9) > 95 % @ 1 65 % @ 0.1 Abexin…”
BackgroundInfluentialMucinous Colorectal Cancer Oxidative Stress and Therapeutic MicroRNAs
Ganesan, H., Kumar, M. M., Banerjee, A., Zhang, H., Sun, X., & Pathak, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_85
Novotny‐Diermayr, V., Sangthongpitag, K., Hu, C. Y., Wu, X., Sausgruber, N., Yeo, P., Greicius, G., Pettersson, S., Liang, A. L., Loh, Y. K., et al. (2023) · doi:10.1158/1535-7163.c.6531900.v1
Novotny‐Diermayr, V., Sangthongpitag, K., Hu, C. Y., Wu, X., Sausgruber, N., Yeo, P., Greicius, G., Pettersson, S., Liang, A. L., Loh, Y. K., et al. (2023) · doi:10.1158/1535-7163.c.6531900
Wilson, A. J., Chüeh, A. C., Tögel, L., Corner, G. A., Ahmed, N., Goel, S., Byun, D., Nasser, S., Houston, M. A., Jhawer, M. P., et al. (2023) · doi:10.1158/0008-5472.22384830.v1
Self-citationWang, T., Chern, E., Hsu, C., Tseng, K.-C., & Chao, H. (2023) · doi:10.1158/0008-5472.c.6511714.v1
Wang, T., Chern, E., Hsu, C., Tseng, K.-C., & Chao, H. (2023) · doi:10.1158/0008-5472.c.6511714
Data from Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp‐Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2023) · doi:10.1158/1078-0432.c.6516984
Fournel, M., Bonfils, C., Yu, H., Yan, P. T., Trachy-Bourget, M.-C., Kalita, A., Liu, J., Lu, A., Zhou, N. Z., Robert, M., et al. (2023) · doi:10.1158/1535-7163.c.6531123
Fournel, M., Bonfils, C., Yu, H., Yan, P. T., Trachy-Bourget, M.-C., Kalita, A., Liu, J., Lu, A., Zhou, N. Z., Robert, M., et al. (2023) · doi:10.1158/1535-7163.c.6531123.v1
Madhusoodanan, S., Panicker, S., & Ramalingam, S. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080292123010008
Additional file 1 of Systematic analysis of histone acetylation regulators across human cancers
Song, C., Liu, X. S., Lin, W., Lai, K., Pan, S., Lu, Z., Li, D., Li, N., & Geng, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23908867
Additional file 3 of Systematic analysis of histone acetylation regulators across human cancers
Song, C., Liu, X. S., Lin, W., Lai, K., Pan, S., Lu, Z., Li, D., Li, N., & Geng, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23908873
Additional file 5 of Systematic analysis of histone acetylation regulators across human cancers
Song, C., Liu, X. S., Lin, W., Lai, K., Pan, S., Lu, Z., Li, D., Li, N., & Geng, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23908879
Additional file 2 of Systematic analysis of histone acetylation regulators across human cancers
Song, C., Liu, X. S., Lin, W., Lai, K., Pan, S., Lu, Z., Li, D., Li, N., & Geng, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23908870
Additional file 4 of Systematic analysis of histone acetylation regulators across human cancers
Song, C., Liu, X. S., Lin, W., Lai, K., Pan, S., Lu, Z., Li, D., Li, N., & Geng, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23908876
Additional file 6 of Systematic analysis of histone acetylation regulators across human cancers
Song, C., Liu, X. S., Lin, W., Lai, K., Pan, S., Lu, Z., Li, D., Li, N., & Geng, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23908882
Niknam, M., Naghibalhossaini, F., Zamani, M., Hosseini, S. V., & Mokarram, P. (2024) · PubMed Central · doi:10.22099/mbrc.2023.48009.1850 · Cited by 1
(R)-9-hsa paraqet efekte antiproliferative më të theksuara krahasuar me (S)-9-hsa
Hysomema, J. (2024) · Optime · doi:10.55312/op.vi2.4465
“HDAC-të e klasës I (HDAC1, HDAC2, HDAC3) lokalizohen në bërthamat e qelizave [9] [10] dhe rezultojnë të hiperaktivizuara në lloje të ndryshme tumoresh [11] [12] [13].”
Pharmacoepigenetics of histone deacetylase inhibitors in cancer
Damaskos, C., Garmpis, N., Dimitroulis, D., Garmpi, A., Valsami, S. I., Effraimidou, E. I., & Kouraklis, G. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18722-3.00018-9
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699756
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699777
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699771
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.25513759
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699786
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699780
Wang, H., Liu, Y.-C., Zhu, C.-Y., Yan, F., Wang, M.-Z., Chen, X.-S., Wang, X.-K., Pang, B., Li, Y.-H., Liu, D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13357289
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699765
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699789
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699768
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699792
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699774
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699759
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26699762
Chen, C., Wang, K., Zhang, Y., Qi, Y., Shen, C., Zhang, Z., Zhang, Z., Yang, H., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.25513792
Linarès, A. (2011) · theses.fr (ABES) · doi:10.70675/b58d4038z85d2z4a6fza2b6z64e5e5b158c3
Al‐lahowani, B., Aswad, T. A., Hajjo, R., Islim, R. A., Bardaweel, S. K., Sweidan, K., Balaji, S., Tiwari, A. K., Abushaikha, G. M., & Sabbah, D. A. (2026) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70324
“PI3K/AKT pathway and histone deacetylase (HDAC-1, HDAC-2, and HDAC-3) regulates Caco-2 growth (Sheng et al. 2003; Wilson et al. 2006).”
Cancer and the gut microbiome: the oncogenic impact of dysbiosis
Aden, D., Darji, K., & Zaheer, S. (2026) · Surgical and Experimental Pathology · doi:10.1186/s42047-026-00244-5 · Cited by 1
Huang, Z., He, Z., Yang, M., Jiang, X., Zhang, N., & Bao, D. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1930569
“Butyrate can suppress HDAC3 activity and subsequently alleviate inflammatory responses while restoring tissue homeostasis (Parada-Venegas et al., 2025; Wilson et al., 2006).”
Kunimoto, A., Kouznetsova, V. L., Kesari, S., & Tsigelny, I. F. (2026) · Biology · doi:10.3390/biology15181570
Ozsamur, N. G., & Erbaş-Çakmak, S. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01448
BindingDB (2022) · UC San Diego · doi:10.7270/q2nc64zs
BindingDB Entry 50021404: Hydrazides as Inhibitors of Histone Deacetylases.
BindingDB (2025) · UC San Diego · doi:10.7270/q2vt1xqm
BindingDB (2022) · UC San Diego · doi:10.7270/q2cz3bwm
Metadata
- Authors
- Wilson, A. J., Byun, D.-S., Popova, N., Murray, L. B., L'Italien, K., Sowa, Y., Arango, D., Velcich, A., Augenlicht, L. H., & Mariadason, J. M.
- Affiliations
- Albert Einstein College of Medicine (US)
- Kyoto Prefectural University of Medicine (JP)
- Vall d'Hebron Institut de Recerca (ES)
- Corresponding author
- Mariadason, John M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 281
- Issue
- 19
- Pages
- 13548-13558
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2105095164
- Semantic Scholar
- c2db47db00c10ecf03aae7c6c6f1c3b194c81502
- Cited by
- 575
- References
- 43
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 31 · 2023: 28 · 2022: 25 · 2021: 18 · 2020: 30 · 2019: 26 · 2018: 27 · 2017: 30 · 2016: 30 · 2015: 38 · 2014: 32 · 2013: 40 · 2012: 28
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5273 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (U01CA088104, R01CA100823, CA88104-04, CA100823-03)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- HDAC3, class I HDACs, colon cancer, histone deacetylase inhibitors, apoptosis, alkaline phosphatase, duodenal adenoma, crypt cells, gene silencing, tumor suppressor
- MeSH terms
- Cell Differentiation, Colon, Colonic Neoplasms, Histone Deacetylases, Humans, Time Factors, Down-Regulation, Up-Regulation, Gene Expression Regulation, Enzymologic, Apoptosis, Caco-2 Cells, Gene Silencing, HCT116 Cells, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.